• Vertex Pharmaceuticals average return on tangible equity for 2024 was 4.04, a 84.76% decline from 2023.
• Vertex Pharmaceuticals average return on tangible equity for 2023 was 26.51, a 16.19% decline from 2022.
• Vertex Pharmaceuticals average return on tangible equity for 2022 was 31.63, a 1.77% decline from 2021.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.